MedOrdyn supports medical device manufacturers in resolving quality system deficiencies and regulatory non-conformities through structured, defensible remediation strategies aligned with global regulatory expectations. Regulatory observations, audit findings, and compliance gaps require more than corrective actions. They require a systematic approach that addresses root causes, strengthens processes, and ensures long-term sustainability. MedOrdyn focuses on restoring compliance while building systems that withstand future audits and inspections.
Our remediation approach integrates regulatory requirements from FDA, EU MDR, ISO 13485, and related standards, ensuring that corrective actions are not only documented but effectively implemented and verified. We work closely with organizations to assess the extent of non-compliance, define remediation priorities, and establish clear action plans supported by objective evidence. This ensures that responses to regulatory bodies are credible, complete, and aligned with expectations.
MedOrdyn provides comprehensive review and reconstruction of Design History Files to ensure alignment with design control requirements under FDA QSR and ISO 13485. Our support includes evaluation of design inputs, outputs, verification, validation, and traceability across the design lifecycle. We ensure that DHF documentation is complete, structured, and capable of demonstrating design control compliance during regulatory inspections and audits.
We support organizations in addressing FDA Warning Letters through structured root cause analysis, corrective action planning, and documentation alignment. MedOrdyn ensures that remediation activities address systemic issues rather than isolated observations. Our approach includes development of comprehensive response strategies, evidence-based justifications, and implementation tracking to restore compliance and regulatory confidence.
MedOrdyn assists in preparing clear, concise, and defensible responses to FDA Form 483 observations. Our support includes evaluation of inspection findings, identification of root causes, and development of robust CAPA plans aligned with regulatory expectations. We focus on ensuring that corrective and preventive actions are practical, measurable, and supported by verification of effectiveness, reducing the risk of repeat observations.
We provide structured gap assessment and remediation support for EU MDR Technical Documentation. This includes alignment with General Safety and Performance Requirements (GSPR), clinical evaluation, risk management integration, and post-market requirements. MedOrdyn ensures that technical files are complete, consistent, and prepared to meet Notified Body expectations during conformity assessments.
MedOrdyn conducts independent, audit-style assessments to evaluate organizational readiness for FDA inspections and Notified Body audits. These mock audits simulate real regulatory conditions, enabling identification of gaps in documentation, processes, and personnel preparedness. We provide detailed findings, risk prioritization, and actionable recommendations to strengthen audit performance and improve confidence during regulatory inspections.